CAS 4707-47-5
:Atrarinsäure
- β-Resorcylic acid, 3,6-dimethyl-, methyl ester
- Atraric acid
- Benzoic acid, 2,4-dihydroxy-3,6-dimethyl-, methyl ester
- Methyl 3,6-dimethyl-β-resorcylate
- Methyl β-orcinolcarboxylate
Methyl-2,4-dihydroxy-3,6-dimethylbenzoate
CAS:Formel:C10H12O4Reinheit:≥ 98.0%Farbe und Form:White to off-white powder or crystalsMolekulargewicht:196.20Methyl 2,4-Dihydroxy-3,6-dimethylbenzoate
CAS:Formel:C10H12O4Reinheit:>98.0%(GC)(T)Farbe und Form:White to Light yellow powder to crystalMolekulargewicht:196.20Atraric acid
CAS:Atraric acid derivatives as a new chemical lead structure for novel therapeutic compounds as AR antagonists, that can be used for prophylaxis or treatment ofFormel:C10H12O4Reinheit:99.59%Farbe und Form:LiquidMolekulargewicht:196.2Methyl Atrarate
CAS:Kontrolliertes ProduktApplications Methyl atratate is used in biological study as role of androgens in inducing distinct response of epithelial-mesenchymal transition factors in human prostate cancer cells.
References Colditz, J., et al.: Mol. Cell. Biochem., 421, 139-147 (2016)Formel:C10H12O4Farbe und Form:NeatMolekulargewicht:196.1999Methyl 2,4-dihydroxy-3,6-dimethylbenzoate
CAS:Methyl 2,4-dihydroxy-3,6-dimethylbenzoate is a natural compound that inhibits the activity of two enzymes that are involved in inflammation. It inhibits the enzyme cyclooxygenase, which converts arachidonic acid to prostaglandin G2 and prostaglandin H2. Methyl 2,4-dihydroxy-3,6-dimethylbenzoate also inhibits the enzyme lipoxygenase, which catalyzes the conversion of linoleic acid to hydroperoxyeicosatetraenoic acid. Methyl 2,4-dihydroxy-3,6-dimethylbenzoate has been shown to be effective against prostate cancer cells and cervical cancer cells. This bioactive phenolic also has antioxidant properties and can inhibit lps stimulated RAW 264.7 cells in vitro by blocking hydrogen bonds between lipopolysaccharide (LPS) and phospholipids on cell
Formel:C10H12O4Reinheit:Min. 95%Farbe und Form:White PowderMolekulargewicht:196.2 g/mol










